| 000 | 01477 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517203156.0 | ||
| 264 | 0 | _c20190405 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1473-558X | ||
| 024 | 7 |
_a10.1097/WNR.0000000000000996 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Jinghui | |
| 245 | 0 | 0 |
_aDisruption of the GluA2/GAPDH complex using TAT-GluA2NT1-3-2 peptide protects against AMPAR-mediated excitotoxicity after epilepsy. _h[electronic resource] |
| 260 |
_bNeuroreport _c03 2018 |
||
| 300 |
_a432-439 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aGlyceraldehyde-3-Phosphate Dehydrogenases _xmetabolism |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 | _aPilocarpine |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, AMPA _xmetabolism |
| 700 | 1 | _aQiao, Nana | |
| 700 | 1 | _aDing, Xiufang | |
| 700 | 1 | _aWang, Jiwen | |
| 773 | 0 |
_tNeuroreport _gvol. 29 _gno. 5 _gp. 432-439 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNR.0000000000000996 _zAvailable from publisher's website |
| 999 |
_c28130887 _d28130887 |
||